Cardiff Oncology, Inc.
CRDFBiotechnology
$0.91+1.60%As of Oct 29vs prior close
- Market cap
- $70.9M
- P/E (TTM)
- –
- From 52W high
- −71.59%
- EPS (LTM)
- -$0.60
- Revenue (LTM)
- $508K
- Net margin
- -7884.06%
Nomior Score
14
Distressed LaggardSpeculativeBottom 4% of the scored universe
Growth47
Quality16
Value38
Momentum19
Resilience30
Growth
+5.04%revenue a year over 9 fiscal years
YE16 $381.1KLTM $508K
Connections
Revenue to profitQ2 YE26
The operating loss was 9245% of revenue, narrower by 2967 pts on a year.
Who owns it
1fund